Sunday, 6 September 2026

Canada: Calgary boy’s arthritis diagnosis highlights a disease many still associate only with old age

From ctvnews.ca

September is Arthritis Awareness Month in Canada, shining a spotlight on a disease that can affect far more than joints — and far more than older adults.

For Calgary’s Riley Ostrowski, the diagnosis came when he was just seven years old, after a frightening and confusing stretch of hospital visits, painful symptoms and months without answers.

He woke early one morning crying and unable to move his neck, prompting his family to take him to hospital.

“I feel like it just stopped all of my physical movement,” said Riley.

“I felt it in my ankles, my shoulders and my wrist and I wasn’t even able to walk up or down the stairs.”

Riley Ostrowski

What followed was a 12-day stay at Alberta Children’s Hospital, along with months of appointments, testing and uncertainty before Riley was eventually diagnosed with systemic juvenile idiopathic arthritis, or systemic JIA.

Riley’s mother, Jennifer Schultz, says that at its worst, the disease affected as many as 14 of her son’s joints.

“He experienced high fevers, rashes, fatigue, and pain and until this happened, we had no clue kids could get arthritis,” she said.

“It took about four months to get the diagnosis, but the fact that we were able to get treated right away was a Godsend because some families have spent more than a year or two years before they got an answer.”

Riley’s mother, Jennifer Schultz, says that at its worst, the disease affected as many as 14 of her son’s joints

Riley was initially treated with anti-inflammatory medication and steroids before moving to biologic therapy.

His family says the medication made a dramatic difference.

“The treatments have been amazing and work very fast,” Schultz said.

Riley initially received treatment intravenously at Alberta Children’s Hospital every few weeks, but has since transitioned to injections at home.

His condition is now largely in remission, and he has returned to many of the activities he enjoys, including playing baseball.

“I sometimes feel like a normal kid. I was freaked out when I first started having to inject these needles, but I feel a lot stronger,” Riley said.

“I love playing baseball, writing comics, and playing video games. So if there are any other kids out there with juvenile arthritis, it’s the love of your family that makes you strong.”

What is juvenile idiopathic arthritis?

Dr. Marinka Twilt, a paediatric rheumatologist at Alberta Children’s Hospital and professor of paediatrics at the University of Calgary, says juvenile idiopathic arthritis is an autoimmune disease in which the immune system mistakenly attacks the body’s own tissues.

The exact cause is not known and is likely influenced by a combination of genetic and environmental factors.

“It’s nothing that a patient or parent has done wrong, and nothing that they could have prevented from it to happen,” Twilt said.

Juvenile arthritis affects an estimated one in 1,000 children.

Twilt says symptoms in children can sometimes be difficult to recognize because younger patients may adapt to pain rather than complain about it.

“They’ll just find another way to still do what they want to do,” she said.

Some children may stop using an affected joint, become unusually tired or lose the ability or willingness to do activities they previously enjoyed. Younger children may suddenly want to be carried more often or stop running and playing.

“If you see that there’s regression in what they could do before, that would be really a sign to go and see a health-care provider,” Twilt said.

Twilt says treatment options for juvenile arthritis have improved significantly, but awareness remains important because earlier diagnosis can help children access effective treatment sooner.

“Awareness is good for the patient that they’re earlier diagnosed, but then when they’re diagnosed, we have to have access to treatment,” she said.

Building support for families

Cassie + Friends, a Canadian charity supporting children with juvenile arthritis and other rheumatic diseases, says roughly 25,000 children across the country are living with those conditions.

“We really want people to understand that kids get arthritis too,” said David Porte, chair and one of the organization’s founders.

Porte helped establish Cassie + Friends after his own daughter, Cassie, was diagnosed with juvenile arthritis at 20 months old.

The organization now provides families with education, financial and emotional support while also connecting children with others facing similar diagnoses.

Cassie + Friends, a Canadian charity supporting children with juvenile arthritis and other rheumatic diseases, says roughly 25,000 children across the country are living with those conditions

Cassie + Friends is holding a Calgary run and walk at Fish Creek Park on Oct. 3, bringing families, doctors and supporters together to raise awareness and funds.

“The medication is great; that’s what treats a disease. But it’s really building this community around it is what lets the families really thrive together,” Porte said.

“We really want people to understand that kids get arthritis too. We really want people to understand what those symptoms are, what they should be looking for if their child has sore joints in the morning, if they’re complaining about pain, that not to overlook it.”

Porte adds that the community events his team runs across Canada are also a chance to build awareness.

One of the challenges is access to treatment.

“The access is not consistent across the country. The access is not consistent for all kids and families, so that is one of the other things that we’re really working on.”

Growing economic burden in Alberta

Arthritis Society Canada is also using Arthritis Awareness Month to highlight the broader impact of the disease.

According to the organization, arthritis carries an estimated $5.1-billion annual economic cost in Alberta through expenses such as medication and hospital care, as well as lost productivity.

Trish Barbato, president and CEO of Arthritis Society Canada, said the report shows another $10 billion is also attributed to social value loss.

“The social impact cost is a new number. It is related to what do people lose because they’re in pain all the time, because they don’t have mobility.”

The cost of pain, reduced mobility, lost independence and the activities people can no longer take part in means arthritis is now the leading cause of disability across Canada.

Barbato adds that the Alberta figures also show the consequences for both individuals and the health-care system.

“It’s a failing of the system. It’s not a failing of individuals who choose to find another path,” Barbato said when discussing the challenges faced by people trying to access arthritis care.

She says improving access to community-based therapy and education could also help people manage the disease and, in some cases, reduce pressure on the health-care system.

“And so when you think about someone who says, ‘I have a bad knee,’ I always joke, ‘You do not have a bad knee. You have end stage arthritis.’”

“If you’re not mobile, if you can’t walk, that is going to impact your job and your ability to be productive.”

The report projects the overall economic and social burden of arthritis in Canada will rise from $142.4 billion annually today to $222.3 billion by 2055, as the number of people living with the disease is expected to grow from more than six million to at least 10 million.

Primary Care Alberta says arthritis can significantly affect a person’s health, independence and quality of life, and that provincial guidance is available to help health-care providers assess and manage the condition.

It says Albertans can also access supports including arthritis education, physiotherapy, self-management workshops and exercise programs.

https://www.ctvnews.ca/calgary/article/calgary-boys-arthritis-diagnosis-highlights-a-disease-many-still-associate-only-with-old-age/ 

Wednesday, 2 September 2026

One injection could keep osteoarthritis drugs working for weeks

From sciencedaily.com

Scientists have created an injectable gel that can remain inside arthritic joints for weeks, slowly releasing medication while also improving lubrication. The approach could make it easier to deliver disease-modifying drugs directly where they are needed while limiting exposure elsewhere in the body. 

Scientists at the University at Buffalo have developed an injectable hydrogel designed to keep osteoarthritis treatments inside the joint for much longer than conventional injections.

After a single minimally invasive injection, the material changes from a liquid into a smooth, lubricating semisolid depot at body temperature. Once in place, it can remain in the joint for several weeks while gradually releasing drug-loaded nanocarriers.

A new injectable gel could turn one shot into weeks of targeted osteoarthritis treatment while helping lubricate damaged joints. Credit: Shutterstock

A Major Challenge in Osteoarthritis Treatment

Osteoarthritis (OA) is one of the world's leading causes of chronic pain and disability. Common treatments delivered directly into joints, including analgesics, corticosteroids, and viscosupplements, can ease symptoms, but their effects are often short-lived, and they do not consistently slow the progression of the disease.

One of the biggest obstacles is that small molecule drugs and biologics can be cleared quickly from synovial fluid. Researchers also face challenges when trying to deliver hydrophobic drugs at concentrations high enough to be effective without increasing exposure throughout the rest of the body.

The University at Buffalo hydrogel platform was designed to address both problems by keeping therapeutic compounds concentrated in the joint and releasing them gradually over time.

A Drug Depot That Forms Inside the Joint

The injectable formulation begins as a liquid, allowing it to be delivered with a minimally invasive procedure. At body temperature, it rapidly becomes a lubricious semisolid material that acts as a local drug reservoir.

The platform combines a biocompatible polymer matrix with drug-loaded nanocarriers. These nanocarriers are designed to carry high amounts of poorly soluble therapeutic compounds, which are otherwise difficult to deliver in an aqueous environment.

The system also uses materials with prior regulatory acceptance, a feature intended to make eventual clinical translation more practical.

Once inside the joint, therapeutic compounds are released through diffusion and gradual relaxation of the hydrogel matrix. This process provides controlled local exposure over multiple weeks rather than allowing the medication to disappear rapidly from the joint.

Researchers have validated the approach using a SIRT6 activator. The platform can also be adapted to carry other hydrophobic disease-modifying compounds.

Longer Lasting Drug Delivery and Joint Lubrication

One potential advantage is a longer therapeutic window. By retaining medication locally for an extended period, the system could reduce how often patients need invasive joint injections while also lowering the possibility of systemic side effects.

The hydrogel was also designed with disease modification in mind. Rather than focusing only on pain relief, it could deliver compounds that target biological processes involved in osteoarthritis, including chronic inflammation and cellular senescence.

Another feature is its dual role inside the joint. The material functions both as a sustained-release drug delivery system and as a viscosupplement, meaning it could potentially improve joint lubrication while simultaneously delivering treatments aimed at the underlying disease.

The platform can carry poorly soluble drugs at relatively high concentrations and can be adapted for different therapeutic payloads and joint applications.

Potential Uses Beyond Knee Osteoarthritis

The primary intended application is knee osteoarthritis (large addressable market).

The same technology could also have potential uses in post-traumatic OA, intervertebral disc degeneration, rotator cuff degeneration, and the localized delivery of other hydrophobic drug candidates.

https://www.sciencedaily.com/releases/2026/08/260829235947.htm

Friday, 28 August 2026

Thumbs up: New thumb joint replacement surgery relieves arthritis pain

From uchicagomedicine.org

The osteoarthritis pain in Mary Wolf’s left thumb was so sharp and intense, it sometimes woke her up in the middle of the night.

It throbbed when she tried to grip or pinch things, making two of her favourite activities — cooking and knitting — nearly impossible.

Daily tasks were also tough: To close a sandwich bag, she would have to tuck it under her left arm and use her “good” right thumb to help zip it shut.

Steroid shots every four months brought temporary relief over a period of three years, but they became less effective over time.

“The pain was ridiculously impacting my life,” said Wolf, 63, a retired fifth grade teacher.

Last spring, Wolf found new hope.

Jeffrey G. Stepan, MD, MSc, her orthopaedic surgeon at the University of Chicago Medicine, became one of only a few hand surgeons in the United States to train on an innovative new implant surgery that replaces a patient’s arthritic thumb joint with a small, prosthetic version.

When the surgery became available at UChicago Medicine in May 2026, Wolf didn’t hesitate.

“I said, ‘Sign me up,’” she said. “I had to do something drastic to change this.”

How does a thumb osteoarthritis implant work?

Thumb osteoarthritis, which causes joint pain at the base of the thumb, is a common condition that affects millions of Americans. It occurs when the protective cartilage that cushions the end of the bones wears away, causing bones to rub against one another.

It’s most common in people over age 50, and it affects women more often than men, according to the American Society for Surgery for the Hand, a medical specialty society.

Treatment starts with a thumb brace, hand therapy and steroid injections.

If the thumb pain persists, patients may choose to have thumb carpometacarpal joint trapeziectomy — a surgery that involves removing the arthritic joint. Although the surgery is effective and has high satisfaction rates, recovery can be painful and take 6 to 9 months, Stepan said.

Meanwhile, doctors in Europe have been performing a simpler and more efficient version of this surgery, using an implant called TOUCH CMC 1 Prosthesis, since 2018.

“Instead of removing the arthritic joint, they were replacing the joint with this implant,” Stepan explained.

Patients who had this implant were pain-free and regained thumb movement in less than six weeks, Stepan said. But the implant, which uses a ball-and-socket design, wasn’t approved for use in the U.S.

When Stepan heard that the U.S. Food and Drug Administration was going to approve this implant, he flew to France in April 2026 to learn how to do the surgery. He is one of only a handful of surgeons in the U.S. who are trained and approved to perform this surgery.

Thumb osteoporosis joint replacement surgery ‘absolutely life-changing’

Wolf had her surgery at the University of Chicago Medical Center in Hyde Park on May 20, 2026, and she was in and out of the hospital in less than five hours.

She received twilight anaesthesia and a nerve block in her shoulder, so she didn’t have feeling in her left arm for 24 hours. But she experienced no side effects. She wore a splint to immobilize her thumb for two weeks, but she was able to move it in “teeny circles” without pain just two days after the surgery.

“I haven’t had any pain since that first night,” she said. “The surgery was absolutely life-changing.”

Since then, Wolf has resumed her cooking and blanket-knitting project.

Stepan, who performed his third thumb osteoporosis joint implant surgery in June, said the option is available for anyone who has struggled with pain in the base of their thumb and wasn’t helped by standard treatments.

“Patients are quickly getting back their strength and getting back their motion,” he said. “Everyone’s been doing really well.”

 https://www.uchicagomedicine.org/forefront/orthopaedics-articles/new-thumb-joint-replacement-surgery

Tuesday, 25 August 2026

Next-gen ankle implants to help young arthritis sufferers regain mobility

From sheffield.ac.uk

By Sean Barton

The next generation of ankle replacements that could restore mobility in young people suffering from a debilitating but overlooked condition, are being developed by a global team of researchers.


  • University of Sheffield researchers are leading a global effort to develop new ankle replacements for young people with ankle osteoarthritis - known as OA
  • OA hits a uniquely young, active demographic - often starting in a person’s 20s or 30s following a severe injury through exercise, sports or accidents
  • The disease is difficult to treat and can leave young people with a devastating compromise: undergo an operation that permanently locks the foot solid (fusion) or accept an artificial joint that may fail in a decade
  • Sheffield is leading a global team of scientists and engineers to develop the next generation of ankle implants that will restore mobility, remove pain and last a lifetime, in what is the EPSRC’s biggest-ever funding award to healthcare technology research

The next generation of ankle replacements that could restore mobility in young people suffering from a debilitating but overlooked condition, are being developed by a global team of researchers. 

Led by Professor Claire Brockett from University of Sheffield’s Insigneo Institute, the research is set to revolutionise treatment for ankle osteoarthritis - a degenerative joint disease that can leave young people facing decades of agonising, progressive mobility loss during their most active years of life.

Unlike knee or hip osteoarthritis, which often develop naturally with age, ankle OA is overwhelmingly post-traumatic - triggered by severe fractures or sprains. This means the majority of people with ankle OA are diagnosed at a much younger age than those who typically need a joint replacement, after sustaining injuries from exercise, sports or accidents.

Current treatments for ankle OA are limited. They range from early management of the disease through physiotherapy, specialised footwear and steroid injections to surgery when the condition worsens. However, as the ankle is a complex joint with a number of small bones and tendons surrounding it, this makes successful surgical intervention difficult to achieve. 

A lack of investment in current treatments means that even when surgeries are successful, patients are often left with chronic pain or limited movement. Consequently, both patients and surgeons tend to postpone the procedure, viewing surgery only as a last resort. 

Previous studies have found that the daily physical and mental toll of living with advanced ankle OA is so severe that it is statistically comparable to suffering from end-stage kidney failure or congestive heart failure, according to patients in the SF-36 survey that measures health-related quality of life. 

Now, an international team of scientists and engineers led by the University of Sheffield has been awarded £12 million - the biggest-ever grant awarded by the Engineering and Physical Sciences Research Council (EPSRC) for healthcare technology research - to develop next generation ankle implants that will restore mobility, reduce pain and last a lifetime. 

Professor Claire Brockett, Professor of Biomechanics at the University of Sheffield, said: “Ankle osteoarthritis leaves patients facing a painful condition and a difficult ultimatum: an ankle fusion, which eliminates pain but permanently locks the bones together and limits movement, or a traditional replacement that preserves some mobility but is typically reserved for older, lighter, or less active patients, and one in 10 will fail within 10 years.

“Our research is looking to give all patients, but particularly younger and more active people, a better option for treatment, so they can continue being active at such an important stage in their lives. We are looking to develop new implants that will last much longer and restore mobility closer to that of the natural ankle.”

The project, called Engineering Advanced Solutions for End-stage Ankle Osteoarthritis (EASE-Ankle OA), is a five year project to tackle Total Ankle Replacement (TAR). It brings together engineers, scientists and clinicians from the University of Sheffield together with researchers from the universities of Birmingham, Warwick, Leeds, Cardiff, Dartmouth College, USA and KU Leuven, Belgium.

Professor Sue Hartley, Vice-President for Research and Innovation at the University of Sheffield, said: “This is an exciting opportunity to work on a significant health problem that has been overlooked in the past. By bringing together diverse expertise, the research will have a profound impact on people's lives, not just in the UK, but globally.

“As the first large grant funded by EPSRC that focuses on the ankle, this project sets a new benchmark for the field - combining a world-leading systematic approach with a commitment to developing the next generation of research leaders to deliver life changing impacts for Total Ankle Replacements patients.”

https://sheffield.ac.uk/news/next-gen-ankle-implants-help-young-arthritis-sufferers-regain-mobility 

Wednesday, 19 August 2026

How to Advocate for Yourself When You Have Psoriatic Arthritis

From everydayhealth.com

Inflamed joints, stiff hands, lower back pain, and fatigue — psoriatic arthritis (PsA) can be difficult to explain when many of your symptoms may be invisible. You might look fine while you're dealing with a flare that’s making everyday tasks like typing, cooking, or keeping up at work harder than they look from the outside.

That gap between how you look and how you feel can make it harder to get the support you need from your doctor, family and friends, and your employer. This is where self-advocacy comes in. It means communicating clearly about your symptoms, speaking up when you need changes to your treatment plan or daily responsibilities, and helping loved ones understand how your condition is affecting your life.

Medical Appointments: Plan Ahead

One of the most important places to advocate for yourself is at your doctor’s office.

Document Your Medical History

Appointments can feel short, so it helps to arrive organized and prepared to ask questions, says Joy Selak, PhD, the co-author ofYou Don’t Look Sick! Living Well With Invisible Chronic Illness, which she wrote alongside her rheumatologist. The book chronicles Dr. Selak’s decades-long journey with two invisible illnesses.

Selak brings a one-page document to her medical appointments, listing her diagnoses, current prescriptions, history of surgeries and medical interventions, and a notes section with questions or topics she wants to cover that day.

“Everything you can do to not take up appointments with data collection, but get right to what the concerns are, can lead to a more meaningful conversation,” she says.

Document which medications you’ve tried, and why they didn’t work, says Arthur Mandelin, MD, PhD, a Chicago-based rheumatologist and an associate professor at the Northwestern University Feinberg School of Medicine. “Without this information, insurance delays in getting access to the next or newest drug can be very lengthy,” Dr. Mandelin says.

Track Your Symptoms Between Appointments

Get specific when tracking your symptoms between appointments, says Alireza Meysami, MD, the head of rheumatology at Henry Ford Health in Detroit, where he specializes in diagnosing and treating inflammatory arthritis, including psoriatic arthritis.

“Patients are experts on how the disease affects their daily lives. The most helpful information is not simply where it hurts, but how it changes what they can and cannot do,” Dr. Meysami says.

Keep track of:

  • Joint pain, swelling or stiffness, and how long morning stiffness lasts
  • Fatigue and how it affects daily activities
  • Skin or nail changes
  • Flare-ups, including what may have triggered them and how long they lasted
  • Amount of prednisone being used, if any

Instead of saying “My pain is worse,” provide examples, such as, “I can’t type for more than 20 minutes” or “I had to stop walking my dog.” “These functional examples help us understand the true impact of the disease and make better treatment decisions,” Meysami says.

This is a crucial step if your doctor needs to fill out paperwork for workplace accommodations, Mandelin says.

Some people rate their pain and functional impairment on a scale of 1 to 10 — with 10 being worst — to help their doctors understand disease severity, Mandelin says.

Take Photos of Symptoms

When possible, take photos of swollen joints, psoriasis plaques, nail changes, or dactylitis (“sausage digits”), Meysami says. He says these details are “extremely valuable” because symptoms can improve before a doctor’s visit.

Push for Treatment Adjustments if Needed

If you have persistent joint pain, worsening psoriasis, or difficulty completing everyday tasks despite treatment, tell your doctor, Meysami says. “Patients should never assume they simply have to ‘live with it,’” he says.

Your rheumatologist can suggest another treatment option, including biologic therapies and targeted oral medications, he says.

Another important sign is needing frequent courses of steroids or relying on pain medications to get through the day.

At Home: Establish a Way to Ask for Help

Getty Images

At home, self-advocacy often starts before you’re in the middle of a flare. Having clear, proactive conversations with family members can make it easier to ask for help when symptoms are flaring.

Have the Conversation Before You Need Help

Instead of waiting until you’re already overwhelmed, try explaining what PsA is like when you’re feeling well, Selak says. Sit your family down and explain what may happen during a flare up. “You need to get out in front of it on a good day. Then you’re both being realistic about what you can and can’t do and when you can and can’t do it,” she says.

That way, loved ones aren’t trying to understand your needs for the first time when you’re already depleted.

Break the ‘I’m Fine’ Habit

Saying “I’m fine” can feel easier than explaining pain or fatigue, especially if you don’t want to seem like you are complaining. But masking symptoms can leave family members unaware of what you’re carrying — and may lead to burnout, resentment, or less support than you actually need, Selak says.

“All of us who have had a chronic illness have done this, where you try to buck it up. There’s no upside to it,” she says. “Don’t pretend you’re okay when you’re not.”

Explain the Impact, Not Just the Feeling

When you’re living with an invisible illness, daily challenges aren’t as obvious as a broken bone or visible injury. But with PsA, common limitations include carrying groceries, typing, cooking, opening jars, climbing stairs, getting dressed, driving long distances, and even playing with the kids, Meysami says.

Instead of saying, “I'm flaring,” he suggests examples, such as, “My hands are too stiff to button my shirt,” “I’m exhausted after grocery shopping,” or “Walking upstairs feels like climbing a mountain today.”

“Describing symptoms in practical, real-world terms is one of the best approaches,” he says. It could be your family’s cue to understand it’s time to pitch in.

At Work: Formalize Your Accommodations

If managing work with PsA symptoms is becoming difficult, it may be time to advocate for yourself and ask for accommodations.

Learn Your Rights

Familiarize yourself with the Americans with Disabilities Act (ADA), your company’s HR policies around time off for appointments and sick leave, and resources available to you, Selak says.

Under the ADA, people whose PsA qualifies as a disability may be protected from discrimination, and you may be able to request reasonable accommodations. And if you can’t work due to your condition, you may be eligible to apply for disability benefits.

Ask for Specific Support

Before talking to HR or your manager, make a short list of what would help you do your job, Selak says. The Job Accommodation Network lists arthritis-related options such as voice-to-text software, typing aids, working from home, or scheduled breaks to stretch. Explain the limitation and a practical fix, Meysami says. “One of the biggest challenges with psoriatic arthritis is that much of the disease is invisible. Patients sometimes worry they'll be viewed as complaining or exaggerating because others cannot see what they're experiencing,” Meysami says.

With Friends: Educate Your Inner Circle

Friendships can become complicated when PsA affects your energy, mobility, or ability to keep plans. The key is to be straightforward, says Elizabeth Medeiros, who was diagnosed with juvenile psoriatic arthritis in 2010 when she was 14 years old, and has since blogged about life with the chronic condition.

Medeiros says her approach depends on the relationship. Long-time friends may already understand her limits and recognize when she needs to slow down, but with newer friends, she’s learned to be upfront about flares, needing to cancel, or adjusting plans.

“Being direct helps, like, ‘I’d really love to come to the museum with you, but the only way I can handle it is if I rent a wheelchair for the day. Is that something you’d be okay with?’” she says.

It also helps to offer another way to connect if you need to cancel, such as inviting a friend over for pizza and a movie or scheduling a FaceTime call instead, she says.

Get Support Beyond Your Rheumatologist

Advocating for your health also means asking for additional support, such as physical therapy or occupational therapy, Mandelin says.

“I refer any patient who asks, whenever they feel ready to ask, including the very first visit if that's what the patient feels they need,” he says.

An occupational therapist can recommend adaptive equipment, provide splints or braces, or teach joint protection techniques, while a physical therapist can help with mobility, flexibility, muscle strength and overall physical function, Meysami says. “Depending on the patient's needs, we may also involve dermatologists, pain specialists, psychologists, nutritionists, or social workers,” he says.

He says patients should feel comfortable asking questions like:

  • Would occupational therapy help me?
  • Would a hand splint or brace make daily activities easier?
  • Could physical therapy improve my mobility?
  • Are there support groups or mental health resources available?

Emotional support matters, too. Medeiros says therapy has been especially helpful during times when family and friends could not support her as much, or when pain and fatigue during flares made it harder to work through her emotions.

“Managing a chronic disease isn't about doing everything alone, it's about using the right tools and support to continue living a full and meaningful life,” Meysami says.

https://www.everydayhealth.com/psoriatic-arthritis/how-to-advocate-for-yourself-with-psoriatic-arthritis/